ES2085234B1 - Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. - Google Patents

Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Info

Publication number
ES2085234B1
ES2085234B1 ES09400362A ES9400362A ES2085234B1 ES 2085234 B1 ES2085234 B1 ES 2085234B1 ES 09400362 A ES09400362 A ES 09400362A ES 9400362 A ES9400362 A ES 9400362A ES 2085234 B1 ES2085234 B1 ES 2085234B1
Authority
ES
Spain
Prior art keywords
procedure
contain
preparation
pharmaceutical compositions
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09400362A
Other languages
English (en)
Spanish (es)
Other versions
ES2085234A1 (es
Inventor
Ges Jose Maria Caldero
Clotet Joan Huguet
Olondriz Francisco Marquillas
Barjoan Pare Dalmases
Rovira Anna Bosch
Acin Joan Roca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES09400362A priority Critical patent/ES2085234B1/es
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to RU95119815A priority patent/RU2126005C1/ru
Priority to AT95907014T priority patent/ATE150752T1/de
Priority to SI9530013T priority patent/SI0695751T1/xx
Priority to PCT/ES1995/000015 priority patent/WO1995023144A1/es
Priority to JP7522150A priority patent/JP2848707B2/ja
Priority to CA002160717A priority patent/CA2160717A1/en
Priority to ES95907014T priority patent/ES2100768T3/es
Priority to AU15381/95A priority patent/AU677146B2/en
Priority to DK95907014.5T priority patent/DK0695751T3/da
Priority to US08/532,672 priority patent/US5658916A/en
Priority to EP95907014A priority patent/EP0695751B1/en
Priority to DE69500198T priority patent/DE69500198T2/de
Publication of ES2085234A1 publication Critical patent/ES2085234A1/es
Application granted granted Critical
Publication of ES2085234B1 publication Critical patent/ES2085234B1/es
Priority to GR970401440T priority patent/GR3023800T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES09400362A 1994-02-24 1994-02-24 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. Expired - Fee Related ES2085234B1 (es)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ES09400362A ES2085234B1 (es) 1994-02-24 1994-02-24 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
US08/532,672 US5658916A (en) 1994-02-24 1995-02-02 Drug active on the central nervous system, a process for the preparation thereof and pharmaceutical compositions containing it
SI9530013T SI0695751T1 (en) 1994-02-24 1995-02-02 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it
PCT/ES1995/000015 WO1995023144A1 (es) 1994-02-24 1995-02-02 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
JP7522150A JP2848707B2 (ja) 1994-02-24 1995-02-02 中枢神経系に作用する薬剤その製造工程及びそれを含む薬剤組成物
CA002160717A CA2160717A1 (en) 1994-02-24 1995-02-02 A drug active on the central nervous system, a process for the preparation thereof and pharmaceutical compositions containing it
ES95907014T ES2100768T3 (es) 1994-02-24 1995-02-02 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
AU15381/95A AU677146B2 (en) 1994-02-24 1995-02-02 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it
RU95119815A RU2126005C1 (ru) 1994-02-24 1995-02-02 3-{2-[4-(6-фторбензо[d]изоксазол-3-ил)-3,6-дигидро-2h-пиридин-1-ил]этил}-2 -метил- 6,7,8,9[-тетрагидропиридо{1,2-a] пиримидин-4-он и его фармацевтически приемлемые соли, способ его получения, способ получения соли 1-[2-(2-метил-4-оксо-6,7,8,9- тетрагидро-4h-пиридо[1,2-a]пиримидин-3-ил)этил]-4-(6-фторбензо[d]изоксазол -3- ил)пиридиния, фармацевтическая композиция
AT95907014T ATE150752T1 (de) 1994-02-24 1995-02-02 Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen
EP95907014A EP0695751B1 (en) 1994-02-24 1995-02-02 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it
DE69500198T DE69500198T2 (de) 1994-02-24 1995-02-02 Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen
DK95907014.5T DK0695751T3 (da) 1994-02-24 1995-02-02 Middel indvirkende på det centrale nervesystem, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende det.
GR970401440T GR3023800T3 (en) 1994-02-24 1997-06-18 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09400362A ES2085234B1 (es) 1994-02-24 1994-02-24 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Publications (2)

Publication Number Publication Date
ES2085234A1 ES2085234A1 (es) 1996-05-16
ES2085234B1 true ES2085234B1 (es) 1997-01-16

Family

ID=8285331

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09400362A Expired - Fee Related ES2085234B1 (es) 1994-02-24 1994-02-24 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES95907014T Expired - Lifetime ES2100768T3 (es) 1994-02-24 1995-02-02 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95907014T Expired - Lifetime ES2100768T3 (es) 1994-02-24 1995-02-02 Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Country Status (12)

Country Link
US (1) US5658916A (da)
EP (1) EP0695751B1 (da)
JP (1) JP2848707B2 (da)
AT (1) ATE150752T1 (da)
AU (1) AU677146B2 (da)
CA (1) CA2160717A1 (da)
DE (1) DE69500198T2 (da)
DK (1) DK0695751T3 (da)
ES (2) ES2085234B1 (da)
GR (1) GR3023800T3 (da)
RU (1) RU2126005C1 (da)
WO (1) WO1995023144A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138908B1 (es) * 1997-08-14 2000-09-16 Vita Invest Sa Polimorfos de la 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-il) 3,6. dihidro-2h-piridin-1-il)-etil)-2-metil-6,7,8,9-tetrahidropirido (1,2-a) pirimidin-4-ona y procedimientos para su obtencion.
ES2141671B1 (es) * 1997-12-26 2001-01-01 Vita Invest Sa Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
HU227118B1 (en) * 2001-11-13 2010-07-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
RU2281085C2 (ru) * 2004-05-25 2006-08-10 Закрытое акционерное общество "Мастерлек" Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
BRPI0809837A2 (pt) * 2007-04-19 2014-11-11 Youxin Li "composto para tratamento de distúrbios mentais, saldo do composto para tratamento de distúrbios mentais, composição farmacéutica e uso do composto para tratamento de distúrbios mentais"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
KR910000165B1 (ko) * 1985-03-27 1991-01-21 쟈안센 파아마슈우티카 엔. 부이. 1,2-벤즈이소옥사졸-3-일과 1,2-벤즈이소티아졸-3-일 유도체의 제조방법
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
CA2000786C (en) * 1988-11-07 1999-01-26 Janssen Pharmaceutica, Naamloze Vennootschap 3-piperidinyl-1,2-benzisoxazoles
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones

Also Published As

Publication number Publication date
WO1995023144A1 (es) 1995-08-31
ATE150752T1 (de) 1997-04-15
ES2100768T3 (es) 1997-06-16
DE69500198T2 (de) 1997-10-16
JPH08509505A (ja) 1996-10-08
EP0695751B1 (en) 1997-03-26
EP0695751A1 (en) 1996-02-07
AU677146B2 (en) 1997-04-10
CA2160717A1 (en) 1995-08-31
RU2126005C1 (ru) 1999-02-10
JP2848707B2 (ja) 1999-01-20
US5658916A (en) 1997-08-19
AU1538195A (en) 1995-09-11
DE69500198D1 (de) 1997-04-30
ES2085234A1 (es) 1996-05-16
DK0695751T3 (da) 1997-09-29
GR3023800T3 (en) 1997-09-30

Similar Documents

Publication Publication Date Title
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
ES2185635T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
ES2110749T3 (es) Derivado de azolilamina.
DK1104759T3 (da) Heteroarylphenylpyrazolforbindelser som antiinflammatoriske/analgetiske midler
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
KR930007907A (ko) 9-(3-시아노페닐)-3,4,6,7,9,10-헥사하이드로-1,8 -(2h,5h)아크리딘디온 화합물
DE60032470D1 (de) Heilmittel die sulfopyranosylacylglycerolderivate enthalten
ZW1992A1 (en) 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
ES2085234B1 (es) Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
ES2189080T3 (es) Derivados de creatina para el asma.
MX9206930A (es) Nuevos compuestos
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
NO20014382D0 (no) Nye immunoundertrykkende middel
NO983217L (no) Terapeutiske anti-astmamidler som inneholder selenforbindeler
PT81314B (pt) Processo para a obtencao de derivados de tiadiazole activos sobre o sistema nervoso central
ES2063700B1 (es) Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
GR79114B (da)
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19940224

Kind code of ref document: B1

Effective date: 19940224

FD1A Patent lapsed

Effective date: 20040916